Resilience, Adaptability, and Efficiency
Executives of Azelis, Biesterfeld, Brenntag, IMCD, and Nordmann share their opinions

The chemical distribution outlook report by Boston Consulting Group, outlined on the previous pages, presents six key findings that capture the strategic pressures and capability shifts transforming the chemical disgtribution landscape, setting the stage for four imperatives that will help distributors to win amid uncertainty. Madjar Navah, one of the authors of the report, introduced the most significant results of the study at the FECC Annual Meeting in Hamburg, Germany, in mid-September. Among the audience were executives of the largest chemical distribution companies, some of which we asked to share their opinions on the report’s conclusions with us. It is obvious that the leaders of Azelis, Biesterfeld, Brenntag, IMCD, and Nordmann share a clear common ground: all five emphasize the need for resilience, adaptability, and efficiency in the face of industry uncertainty and transformation. They highlight the importance of building robust and flexible supply chains, investing in digital and technological capabilities, and most notably, prioritizing their people. They also stress the balance between operational efficiency and forward-looking investments, particularly in digitalization and sustainability. Ultimately, the leaders agree that the future of chemical distribution will be shaped by those who combine technological advancement with human expertise, collaboration, and strong customer focus.
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
most read

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0

Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.











